![CA 72-4 marker: adjunct to conventional biomarkers in monitoring of pancreatic, ovarian and colorectal cancers. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc. CA 72-4 marker: adjunct to conventional biomarkers in monitoring of pancreatic, ovarian and colorectal cancers. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc.](https://www.advimmuno.com/wp-content/uploads/2019/04/CA72-4.jpeg)
CA 72-4 marker: adjunct to conventional biomarkers in monitoring of pancreatic, ovarian and colorectal cancers. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc.
![Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study](https://www.mdpi.com/cancers/cancers-11-00733/article_deploy/html/images/cancers-11-00733-g001-550.jpg)
Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study
![Tumor Marker:- Part 4 – CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 – Labpedia.net Tumor Marker:- Part 4 – CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 – Labpedia.net](https://labpedia.net/wp-content/uploads/2020/01/Tumor-marker-diagnosis-prognosis-3.jpg)
Tumor Marker:- Part 4 – CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 – Labpedia.net
![Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries | Anticancer Research Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/37/7/3649/F1.large.jpg)
Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries | Anticancer Research
![The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass - American Journal of Obstetrics & Gynecology The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass - American Journal of Obstetrics & Gynecology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b9a47261-1988-4af7-85b1-b8402d5beaf5/gr1.jpg)
The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass - American Journal of Obstetrics & Gynecology
![CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy | BMC Cancer | Full Text CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07666-8/MediaObjects/12885_2020_7666_Fig3_HTML.png)
CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy | BMC Cancer | Full Text
![Clinical risk factors of gastric cancer (GC) and tumor markers in high... | Download Scientific Diagram Clinical risk factors of gastric cancer (GC) and tumor markers in high... | Download Scientific Diagram](https://www.researchgate.net/publication/333406730/figure/tbl1/AS:763345779052544@1559007224001/Clinical-risk-factors-of-gastric-cancer-GC-and-tumor-markers-in-high-and-normal-CA72-4.png)
Clinical risk factors of gastric cancer (GC) and tumor markers in high... | Download Scientific Diagram
![Diagnostic values of serum tumor markers CA72-4, SCCAg, CYFRA21-1, NSE, AFU, CA125, CA19-9, CEA and FER in nasopharyngeal carcinoma | Semantic Scholar Diagnostic values of serum tumor markers CA72-4, SCCAg, CYFRA21-1, NSE, AFU, CA125, CA19-9, CEA and FER in nasopharyngeal carcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b7e7c079f7d85b1c984a0c0904f5b0d1f4267c64/3-Table1-1.png)
Diagnostic values of serum tumor markers CA72-4, SCCAg, CYFRA21-1, NSE, AFU, CA125, CA19-9, CEA and FER in nasopharyngeal carcinoma | Semantic Scholar
![Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - Clinical Gastroenterology and Hepatology Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - Clinical Gastroenterology and Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5e6a3bad-025f-4e08-a863-268e17649522/gr1_lrg.jpg)
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - Clinical Gastroenterology and Hepatology
![Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers - SciAlert Responsive Version Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers - SciAlert Responsive Version](https://docsdrive.com/images/academicjournals/ijcr/2006/tab3-2k6-50-56.gif)
Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers - SciAlert Responsive Version
![PDF] COMPARISON OF CEA AND CA 19-9 WITH CA 72-4 IN PATIENTS WITH UPPER GASTROINTESTINAL CARCINOMAS IN LOCAL POPULATION | Semantic Scholar PDF] COMPARISON OF CEA AND CA 19-9 WITH CA 72-4 IN PATIENTS WITH UPPER GASTROINTESTINAL CARCINOMAS IN LOCAL POPULATION | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/021403774254c3cc364ff5c2c6244ec55a8b5f58/2-Table1-1.png)